Purple Biotech Ltd. American Depositary Shares

PPBT XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

2.8M

Short interest (May 15)

0.8%

Net Short (Jun 03 ): -0.1%

Borrow Fee

41.20%

↑ 191.7%

Available Shares

50K

↑ 231.6%

Price Chart

Company Overview

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Company Info

Exchange: NASDAQ

CIK: 0001614744

Asset Type: ADRC

Market Data

Market Cap: $2,806,144

Employees: 10

Status: Active

Short Interest

Current Borrow Fee 41.20%

Range: 41.20% - 51.60%

Available Shares 50K

Range: 30K - 45K

Recent Changes

Fee Change: ↓ 7.1%

Available Change: ↑ 5.6%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime